Back to Search
Start Over
Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105).
- Source :
- Cancer Science; Sep2022, Vol. 113 Issue 9, p3267-3270, 4p
- Publication Year :
- 2022
Details
- Language :
- English
- ISSN :
- 13479032
- Volume :
- 113
- Issue :
- 9
- Database :
- Complementary Index
- Journal :
- Cancer Science
- Publication Type :
- Academic Journal
- Accession number :
- 159025570
- Full Text :
- https://doi.org/10.1111/cas.15484